New radiation dose aims to tame eye cancer with fewer side effects
NCT ID NCT07210749
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests a medium-dose radiation therapy (12 Gy in 6 sessions) for people with low-grade B-cell lymphoma in the eye area. The goal is to find a dose that controls the cancer better than very low doses but causes fewer long-term side effects than the standard higher dose. About 36 adults with this condition will take part to see if this approach works well and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORBITAL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer Vancouver
Vancouver, British Columbia, V5Z4E6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.